Monopar Therapeutics Inc (NQ: MNPR )
0.5990
+0.0090
(+1.53%)
Streaming Delayed Price
Updated: 10:58 AM EDT, Sep 25, 2023
Add to My Watchlist
Headline News about Monopar Therapeutics Inc














Monopar Stock Gains On Launch Of Early Stage Soft Tissue Cancer Trial With Camsirubicin
August 03, 2021
Via Benzinga
Exposures
Product Safety





Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.